- Home
- DEA vs IRMD Comparison
DEA vs IRMD Comparison
Compare DEA & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DEA | IRMD |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | DEA | IRMD |
|---|---|---|
| Price | $23.93 | $96.96 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 1 |
| Target Price | $23.49 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 309.5K | 121.8K |
| Earning Date | 04-27-2026 | 05-01-2026 |
| Dividend Yield | ★ 7.77% | 0.95% |
| EPS Growth | ★ 50.00 | 16.67 |
| EPS | 0.02 | ★ 0.45 |
| Revenue | ★ $336,099,000.00 | $83,814,000.00 |
| Revenue This Year | $5.41 | $12.38 |
| Revenue Next Year | $3.33 | $11.31 |
| P/E Ratio | $1,193.00 | ★ $213.33 |
| Revenue Growth | 11.27 | ★ 14.43 |
| 52 Week Low | $20.56 | $55.11 |
| 52 Week High | $24.94 | $107.90 |
Technical Indicators
Market Signals| Indicator | DEA | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 64.81 |
| Support Level | $23.46 | $95.65 |
| Resistance Level | $24.36 | $97.36 |
| Average True Range (ATR) | 0.38 | 3.16 |
| MACD | -0.01 | 0.72 |
| Stochastic Oscillator | 46.73 | 86.52 |
Price Performance
Historical ComparisonAbout DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.